Axe Compute Inc (AGPU)

Dec 12, 2025, 8:00 AM EST - 14 days ago

Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure

Nov 17, 2025, 12:07 PM EST - 5 weeks ago

Predictive Oncology Inc. (POAI) Q3 2025 Earnings Call Prepared Remarks Transcript

Nov 14, 2025, 5:12 PM EST - 5 weeks ago

Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy

Oct 14, 2025, 8:00 AM EDT - 2 months ago

Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy

Oct 8, 2025, 9:00 AM EDT - 2 months ago

Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy

Sep 29, 2025, 9:07 AM EDT - 3 months ago

Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens

Sep 25, 2025, 8:00 AM EDT - 3 months ago

Predictive Oncology Announces 1-for-15 Reverse Stock Split

Sep 4, 2025, 9:00 AM EDT - 4 months ago

Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients

Aug 19, 2025, 9:44 PM EDT - 4 months ago

PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Aug 14, 2025, 7:00 AM EDT - 4 months ago

Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jul 8, 2025, 9:00 AM EDT - 6 months ago

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

Jun 12, 2025, 8:30 AM EDT - 7 months ago

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

May 27, 2025, 8:35 AM EDT - 7 months ago

Court Denies Renovaro Motion for an Expedited Trial in July

May 22, 2025, 8:15 AM EDT - 7 months ago

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition

May 20, 2025, 8:30 AM EDT - 7 months ago

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"

May 15, 2025, 7:00 AM EDT - 8 months ago

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

Apr 1, 2025, 7:00 AM EDT - 9 months ago

Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update

Mar 25, 2025, 7:00 AM EDT - 9 months ago

Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary

Mar 20, 2025, 7:00 AM EDT - 10 months ago

Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries

Feb 19, 2025, 5:20 PM EST - 11 months ago

Predictive Oncology Closes Registered Direct Offering

Feb 18, 2025, 8:00 AM EST - 11 months ago

Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing

Feb 12, 2025, 2:00 PM EST - 11 months ago

Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform

Jan 30, 2025, 7:00 AM EST - 11 months ago

AIRNA Appoints Matthew Hawryluk as Chief Business Officer

Jan 16, 2025, 8:00 AM EST - 1 year ago

Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay

Jan 7, 2025, 6:51 PM EST - 1 year ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

LNAI

Jan 6, 2025, 9:10 AM EST - 1 year ago

Predictive Oncology Announces Agreement to be Acquired by Renovaro

Nov 13, 2024, 7:00 AM EST - 1 year ago

Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update

Sep 5, 2024, 8:00 AM EDT - 1 year ago

Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 14, 2024, 12:47 PM EDT - 1 year ago

Predictive Oncology Inc. (POAI) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 7, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

Jul 26, 2024, 8:00 AM EDT - 1 year ago

Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds

Jul 25, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results

Jun 11, 2024, 8:00 AM EDT - 1 year ago

Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)

Jun 4, 2024, 8:42 AM EDT - 1 year ago

Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery

May 29, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024

May 28, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

May 15, 2024, 5:34 PM EDT - 1 year ago

Predictive Oncology Inc. (POAI) Q1 2024 Earnings Call Transcript

May 15, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update

May 10, 2024, 7:00 AM EDT - 1 year ago

Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024

Apr 24, 2024, 4:05 PM EDT - 1 year ago

Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Apr 1, 2024, 10:25 AM EDT - 1 year ago

Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 5:28 PM EDT - 1 year ago

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update

Feb 21, 2024, 4:05 PM EST - 2 years ago

Predictive Oncology to Participate in Upcoming Investor Conferences

Jan 2, 2024, 7:00 AM EST - 2 years ago

Predictive Oncology to Participate in Upcoming San Francisco Conferences

Nov 14, 2023, 1:27 PM EST - 2 years ago

Predictive Oncology Inc. (POAI) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 7:00 AM EST - 2 years ago

Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 8, 2023, 8:12 AM EST - 2 years ago

Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital

Aug 10, 2023, 11:56 PM EDT - 2 years ago

Predictive Oncology, Inc. (POAI) Q2 2023 Earnings Call Transcript